Evidence
Ageing Res Rev. 2024 Feb 13:102233. doi: 10.1016/j.arr.2024.102233. Online ahead of print.
ABSTRACT
The ketogenic diet (KD) is a low-carbohydrate, adequate protein and high-fat diet. KD is primarily used to treat refractory epilepsy. KD was shown to be effective in treating different neurodegenerative diseases. Alzheimer disease (AD) is the first common neurodegenerative disease in the world characterized by memory and cognitive impairment. However, the underlying mechanism of KD in controlling of AD and other neurodegenerative diseases are not discussed widely. Therefore, this review aims to revise the fundamental mechanism of KD in different neurodegenerative diseases focusing on the AD. KD induces a fasting-like which modulates the central and peripheral metabolism by regulating mitochondrial dysfunction, oxidative stress, inflammation, gut-flora, and autophagy in different neurodegenerative diseases. Different studies highlighted that KD improves AD neuropathology by regulating synaptic neurotransmission and inhibiting of neuroinflammation and oxidative stress. In conclusion, KD improves cognitive function and attenuates the progression of AD neuropathology by reducing oxidative stress, mitochondrial dysfunction, and enhancing neuronal autophagy and brain BDNF.
PMID:38360180 | DOI:10.1016/j.arr.2024.102233
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
🌐 90 Days
Evidence Blueprint
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence